SUMO-1 CRISPR Knockout and Activation Products (h)

Por um escritor misterioso

Last updated 09 abril 2025

SUMO-1 CRISPR Knockout and Activation Plasmids (h) designed to edit, knockdown or upregulate human SUMO-1 gene expression

PARP1 CRISPR Knockout and Activation Plasmids (h) designed to edit, knockdown or upregulate human PARP-1 gene expression. Cited in 3 publications

PARP1 CRISPR Knockout and Activation Products (h) | SCBT - Santa Cruz Biotechnology

Quantitative SUMO proteomics identifies PIAS1 substrates involved in cell migration and motility

Biomolecules, Free Full-Text

CRISPR-Cas knockout of miR21 reduces glioma growth: Molecular Therapy - Oncolytics

Frontiers Identification of UBE2I as a Novel Biomarker in ccRCC Based on a Large-Scale CRISPR-Cas9 Screening Database and Immunohistochemistry

CRISPR-UMI: single-cell lineage tracing of pooled CRISPR–Cas9 screens

Exo1-protected DNA nicks direct crossover formation in meiosis

Biomimetic Mineralization-Based CRISPR/Cas9 Ribonucleoprotein Nanoparticles for Gene Editing

Frontiers SUMOylation Connects Cell Stress Responses and Inflammatory Control: Lessons From the Gut as a Model Organ

Alternative CRISPR Discovered @MIT Leaders in Pharmaceutical Business Intelligence (LPBI) Group

Sm B/B' CRISPR Knockout and Activation Products (h)

FAT10 inhibits SUMO activation by AOS1/UBA2. a In vitro

Immunohistochemical analyses of SUMO-1 (A, B, E, and F) and SUMO-2/3

Crosstalk between SUMOylation and ubiquitylation controls DNA end resection by maintaining MRE11 homeostasis on chromatin

Identification of DAXX as a restriction factor of SARS-CoV-2 through a CRISPR/Cas9 screen

Recomendado para você